The Congenital Heart Disease Genetic Network Study: rationale, design, and early results

Area of Science:

• Cardiovascular Genetics
• Pediatric Cardiology
• Genomic Medicine

Background:

• Congenital heart defects (CHD) are the primary cause of infant mortality from birth defects, with significant long-term health issues.
• While genetics play a crucial role in CHD etiology, the specific genetic causes remain unidentified for the majority of affected individuals.
• The Pediatric Cardiac Genomics Consortium (PCGC) was established to address this knowledge gap.

Purpose of the Study:

• To investigate the complex relationships between genetic factors, clinical manifestations, and patient outcomes in congenital heart defects.
• To leverage a large-scale, multi-site study to uncover the genetic underpinnings of various CHD types.
• To build a comprehensive resource for the scientific community to advance CHD research.

Main Methods:

• Establishment of the Congenital Heart Disease Genetic Network Study by the PCGC, involving 10 clinical sites.
• Collection of extensive clinical data and biospecimens (blood, saliva, tissue) from CHD probands and their parents.
• Utilization of core laboratory infrastructure for genotyping, whole-exome sequencing, and variant confirmation.

Main Results:

• Enrollment of 3772 probands between December 2010 and June 2012, with parental data for 72%.
• A genetic diagnosis was identified in approximately 11% of probands.
• High-quality DNA was successfully obtained from 97% of blood and 91% of saliva samples, facilitating genomic analysis.

Conclusions:

• The PCGC has created a valuable resource for studying the genetic basis of CHD.
• Genomic analyses are ongoing for specific CHD subtypes, promising further insights into disease mechanisms.
• The study highlights the importance of genetic investigations in understanding and managing congenital heart defects.